DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,000 | +24.6% | 8,010 | +57.7% | 0.00% | – |
| Q2 2023 | $57,000 | +72.7% | 5,078 | +72.8% | 0.00% | – |
| Q1 2023 | $33,000 | -40.0% | 2,938 | -37.9% | 0.00% | – |
| Q4 2022 | $55,000 | +175.0% | 4,734 | +205.6% | 0.00% | – |
| Q3 2022 | $20,000 | +122.2% | 1,549 | +15.5% | 0.00% | – |
| Q2 2022 | $9,000 | -69.0% | 1,341 | -55.4% | 0.00% | – |
| Q1 2022 | $29,000 | -67.0% | 3,009 | -59.5% | 0.00% | – |
| Q4 2021 | $88,000 | +8.6% | 7,438 | +50.4% | 0.00% | – |
| Q3 2021 | $81,000 | +88.4% | 4,946 | +140.1% | 0.00% | – |
| Q2 2021 | $43,000 | +79.2% | 2,060 | +33.6% | 0.00% | – |
| Q1 2021 | $24,000 | +71.4% | 1,542 | +135.1% | 0.00% | – |
| Q4 2020 | $14,000 | – | 656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |